HK-listed Ocumension Therapeutics hits near 5-month high on share sale plan

Ocumension Therapeutics

10/06/2021 05:58

** Shares of Ocumension Therapeutics  1477.HK  rise as much
as 9.6% to HK$32.05, their highest since Jan. 18, and on course
for second session of gains
    ** Stock on track for the best day since May 31
    ** China-based ophthalmic therapies developer says major
shareholders plan sale of 1.36% of the company stake to
third-party investors for HK$236.5 mln ($30.5 mln)  urn:newsml:reuters.com:*:nFWN2NR13Q
    ** The major shareholders, including 6 Dimensions Capital, 6
Dimensions Affiliates Fund, Suzhou Frontline BioVentures Venture
Capital Fund II, and Suzhou 6Dimensions Venture Capital
Partnership, plan sale of 8.6 mln existing shares at HK$27.50
each, or 6% discount to Wednesday's close 
    ** Co says it does not expect the placing to have any
adverse effect on its operations
    ** Morgan Stanley & Co International PLC is the placing
agent 
    ** Hong Kong's healthcare index  .HSCIH  climbs 0.6%
    ** Both the Hang Seng China enterprises index  .HSCE  and
the benchmark index  .HSI  gain 0.3%
    ** As of last close, the stock had risen 8.3% this year 


($1 = 7.7596 Hong Kong dollars)

 (Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)